Heyer and Dr. Jennifer Bauwens, Director of the Center for Family Studies at the Family Research Council, spoke to Fox News Digital about their new book, “Embracing God’s Design,” which ...

The fourth season of Power Book III: Raising Kanan is in our rearview — the series will eventually return for a fifth and final season — which means Power fans are now focusing on the next ...

One Trump adviser wondered aloud what might be in “Elon’s burn book,” and if the Tesla chief would ever feel compelled to deploy its contents if the name-calling between Trump and Musk ...

Resecabtagene autoleucel (rese-cel) is a CD19-directed CAR T-cell therapy that CABA is developing for autoimmune diseases. In many respects, it is similar to already-approved CAR T-cell products ...

The Royal Australian Mint has released a coin collection celebrating The Australian Women's Weekly Children's Birthday Cake Book. Designs are inspired by a series of iconic cakes, including the ...

Marc Raimondi, the former New York Post writer and current Falcons beat reporter for ESPN, is taking a look at WCW’s famed faction through a pop culture lens in his upcoming book “Say Hello to ...

“Not My Type: One Woman vs. a President” includes reflections on being asked to testify about her sex life, as well as the thrill of winning two lawsuits. By Alexandra Alter John Birdsall ...

FSG pulls in a hot history of the artificial intelligence industry, two major names in music sell two new books, and more in this week’s book deals.

Among the speakers on the opening day of the Borders Book Festival in Melrose is the actor, writer and presenter Sir Michael Palin. The festival will also see the announcement of the winner of the ...

Here we review the latest titles.See all 51 stories. This week’s book reviews range from magical realism and Australian grunge to a study of WWII’s aftermath and a guide to talking your way ...

Determining the book value of a company is more difficult than finding its market value, but it can also be far more rewarding. Many famous investors, including billionaire Warren Buffett ...

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product ...